Amneal Pharmaceuticals Inc. Revenue 2016–2025
Amneal Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Amneal Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 722.5 M, a 3.90% increase year-over-year.
- Amneal Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 2.9 B, a 9.07% increase year-over-year.
- Amneal Pharmaceuticals Inc. annual revenue for 2025 was 3.0 B, a 8.05% increase from 2024.
- Amneal Pharmaceuticals Inc. annual revenue for 2024 was 2.8 B, a 16.73% increase from 2023.
- Amneal Pharmaceuticals Inc. annual revenue for 2023 was 2.4 B, a 8.20% increase from 2022.
- Amneal Pharmaceuticals Inc. annual revenue for 2022 was 2.2 B.
Amneal Pharmaceuticals Inc. (AMRX) — Frequently Asked Questions
Amneal Pharmaceuticals Inc. (AMRX) is a publicly traded US company. It has a market capitalization of $4.98B. In fiscal 2025 it reported revenue of $3.02B and net income of $72M. Explore AMRX's stock price, financial statements, earnings history, margins and key ratios below.
What is Amneal Pharmaceuticals Inc.'s market cap?
Amneal Pharmaceuticals Inc. (AMRX) has a market capitalization of $4.98B.
What is the AMRX stock price?
AMRX trades at $15.32 (+4.29% on the day).
How much revenue does Amneal Pharmaceuticals Inc. make?
Amneal Pharmaceuticals Inc. reported revenue of $3.02B in fiscal 2025.
Is AMRX profitable?
In fiscal 2025, Amneal Pharmaceuticals Inc. reported net income of $72M.